Fischer Medical Ventures Reports Robust Q2 Growth with 46-Fold Increase in Net Profit Oct 28, 2025
Fischer Medical Ventures, a medical technology company, reported a significant financial performance boost in Q2. Net profit surged to 139.00 million rupees from 3.00 million rupees year-over-year, a 46-fold increase. Revenue more than doubled to 863.00 million rupees from 397.00 million rupees. The company also announced board changes, appointing Mr. Chan Sing En as Additional Non-Executive Independent Director and recommending Tan Sri Dato' Dr. Syed Jalaludin as Independent Director, both for five-year terms subject to shareholder approval.